Business Wire

AppLogic Networks Secures Commitment from Leading MSP to Unlock New Revenue Paths with Edge-Ready, AI-Driven QoE Platform

4.8.2025 15:43:00 CEST | Business Wire | Press Release

Share

AppLogic Networks, a leader in software-based application visibility and performance optimization, today announced that a leading, next-generation managed service provider has adopted its AI-powered visibility platform, focused on end customers’ high value, high expectation digital experiences, including for maritime travel. The deployment reflects a pivotal industry shift: Quality of Experience (QoE) is no longer a technical metric; it’s a business imperative.

Vacationers on cruise ships spending thousands on premium travel experiences now expect premium digital access as part of the package. For many operators, internet connectivity has quietly become one of the most important services on a global scale, both in terms of guest satisfaction and revenue potential. With internet access packages playing an increasingly critical role in the business model, ensuring flawless digital service – including no service leakage, blind spots, and reputational risk – has become essential.

“This isn’t just another service integration, it’s a commercial unlock for our customers,” said Hashem Eid, Chief Commercial Officer at AppLogic Networks. “QoE now sits at the heart of brand reputation and revenue realization. We’re proud to support our customers as they turn premium connectivity into a competitive advantage.”

This deployment brings AppLogic Networks’ advanced application classification, real-time QoE scoring, and personalized policy control to a fleet of performance-critical, fair-usage-challenged sites. It represents a growing realization that the digital experience ecosystem has moved from connectivity services to experience-based services.

“Our transition to a software-only model was a deliberate strategy to meet this moment,” said Samir Marwaha, Chief Solutions Officer at AppLogic Networks. “By untethering our insights and world-class traffic management from proprietary hardware, we’re giving operators the flexibility, speed, and reach to support growth across maritime, satellite, telecom, mobile private networks, and managed services. This level of QoE-centric control is vital to satisfy the digital experience users have come to expect.”

AppLogic Networks’ software suite delivers:

  • Deep application visibility and classification at scale
  • Behavioral and sentiment insights tied to real user experience
  • Seamless integration with world-class traffic and policy engines
  • A foundation for AI, Agentic AI, and GenAI-powered network intelligence

As the demand of uninterrupted, high-quality services rises in all corners of the world, AppLogic Networks is helping managed service providers and other network providers to unlock new opportunities by making the internet exceptional, with App QoE everywhere.

About AppLogic Networks

AppLogic Networks is on a mission to revolutionize network observability while serving as a champion of digital human rights. The company provides AI-powered application and network intelligence software solutions that help network operators analyze, optimize, and monetize their networks with contextual insights and real-time metrics—ultimately enabling the delivery of high-quality online experiences. AppLogic Networks is based in the US, with customers located in democracies around the globe.

For more information on AppLogic Networks’ Application Classification solutions, visit www.applogicnetworks.com.

More about this topic? Please visit our blog.

Follow AppLogic Networks on LinkedIn and Bluesky

Topics: App Quality of Experience, App QoE, AppLogic Networks

View source version on businesswire.com: https://www.businesswire.com/news/home/20250804165841/en/

Contacts

Pro-AppLogicNetworks@Prosek.com

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press Release

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (

Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:19:00 CEST | Press Release

Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press Release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta

inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press Release

inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and

Brenus Pharma's Novel In Vivo Immunotherapy STC-1010 Shows Safety, Activating T Cells in First-Line MSS Metastatic Colorectal Cancers With 2 Complete Responses.23.10.2026 14:50:00 CEST | Press Release

Brenus Pharma, a clinical-stage biotech company, announced first data from the Phase Ia dose escalation of BreAK CRC-001. Nine unresectable patients were treated; 89% had liver metastases and 89% KRAS-mutant tumors, a population refractory to immunotherapy. Median follow-up: 8 months (1–14; data cut-off 6/08/2026). 95% of metastatic colorectal cancers are pMMR/MSS tumors, poorly immunogenic and resistant to immunotherapy. STC-1010, the company’s lead in vivo DC-engager, is designed to make these “cold” tumors visible to immune cells. Safety: no dose-limiting toxicity, only grade 1–2 related adverse events. Clinical activity (seven evaluable patients, RECIST 1.1): 100% disease control, 57% objective response rate (4/7). 43% of patients became operable (3/7): two with no evidence of disease afterward. Molecular profile: ctDNA dropped by up to 97% within two months, TP53 and KRAS mutations near undetectable. Immune activity (first six patients): STC-1010 regimen nearly quadrupled cytotoxi

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye